• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery.咪唑并嘧啶:从相对奇特的骨架到药物研发中不断演变的结构基序。
RSC Med Chem. 2024 Mar 13;15(5):1488-1507. doi: 10.1039/d3md00718a. eCollection 2024 May 22.
2
Pyrimidine-fused Dinitrogenous Penta-heterocycles as a Privileged Scaffold for Anti-Cancer Drug Discovery.嘧啶稠合二氮杂五元环作为抗癌药物发现的优势骨架
Curr Top Med Chem. 2022 Mar 4;22(4):284-304. doi: 10.2174/1568026622666220111143949.
3
Anticancer and Antibacterial Activeness of Fused Pyrimidines: Newfangled Updates.稠合嘧啶的抗癌和抗菌活性:最新进展
Bioorg Chem. 2024 Dec;153:107780. doi: 10.1016/j.bioorg.2024.107780. Epub 2024 Sep 3.
4
Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.解锁苯并咪唑衍生物的药理潜力:药物开发之路。
Curr Top Med Chem. 2024;24(5):437-485. doi: 10.2174/0115680266283641240109080047.
5
A Profound Insight into the Structure-activity Relationship of Ubiquitous Scaffold Piperazine: An Explicative Review.深入探讨普遍存在的哌嗪支架的结构-活性关系:解释性综述。
Med Chem. 2024;20(1):17-29. doi: 10.2174/0115734064244117230923172611.
6
FDA-approved drugs containing dimethylamine pharmacophore: a review of the last 50 years.美国食品药品监督管理局批准的含二甲胺药效基团的药物:过去50年回顾
RSC Adv. 2024 Sep 2;14(38):27657-27696. doi: 10.1039/d4ra04730c. eCollection 2024 Aug 29.
7
Thiazolopyrimidine, a privileged scaffold: Recent updates on synthetic and pharmacological perspective in drug discovery.噻唑并嘧啶,一种优势骨架:药物发现中合成与药理学视角的最新进展。
Arch Pharm (Weinheim). 2025 Mar;358(3):e2400870. doi: 10.1002/ardp.202400870.
8
Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold.喹诺酮衍生物作为多功能骨架的生物活性和构效关系的最新见解。
Bioorg Med Chem. 2022 Apr 1;59:116674. doi: 10.1016/j.bmc.2022.116674. Epub 2022 Feb 18.
9
Antiviral Activities of Pyridine Fused and Pyridine Containing Heterocycles, A Review (from 2000 to 2020).吡啶稠合及含吡啶杂环的抗病毒活性综述(2000年至2020年)
Mini Rev Med Chem. 2021;21(17):2584-2611. doi: 10.2174/1389557521666210126143558.
10
Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship.天然产物吴茱萸碱启发的药物化学:抗癌活性、结构优化及构效关系
Eur J Med Chem. 2023 Feb 5;247:115031. doi: 10.1016/j.ejmech.2022.115031. Epub 2022 Dec 17.

引用本文的文献

1
Visible Light-Mediated Preparation of a Key Intermediate Employed in the Synthesis of Zolpidem and Several Analogs.可见光介导制备用于合成唑吡坦及几种类似物的关键中间体。
Chem Asian J. 2025 Aug;20(16):e00455. doi: 10.1002/asia.202500455. Epub 2025 May 13.
2
Synthesis and antimycotic activity of new derivatives of imidazo[1,2-]pyrimidines.咪唑并[1,2 - ]嘧啶新衍生物的合成及抗真菌活性
Beilstein J Org Chem. 2024 Nov 5;20:2806-2817. doi: 10.3762/bjoc.20.236. eCollection 2024.

本文引用的文献

1
Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review.基于咪唑并吡啶的激酶抑制剂作为潜在的抗癌药物:综述。
Bioorg Chem. 2023 Nov;140:106831. doi: 10.1016/j.bioorg.2023.106831. Epub 2023 Sep 3.
2
Time-dependent variations in BK polyomavirus genome from kidney transplant recipients with persistent viremia.与持续性病毒血症的肾移植受者相关的 BK 多瘤病毒基因组的时间依赖性变化。
Sci Rep. 2023 Aug 19;13(1):13534. doi: 10.1038/s41598-023-40714-4.
3
Advances in the synthesis of nitrogen-containing heterocyclic compounds by benzyne cycloaddition.通过苯炔环加成反应合成含氮杂环化合物的研究进展。
RSC Adv. 2023 Mar 13;13(12):8238-8253. doi: 10.1039/d3ra00400g. eCollection 2023 Mar 8.
4
Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia.发现 MK-8189,一种高效且选择性的 PDE10A 抑制剂,用于治疗精神分裂症。
J Med Chem. 2023 Jan 26;66(2):1157-1171. doi: 10.1021/acs.jmedchem.2c01521. Epub 2023 Jan 9.
5
WHO releases first-ever list of health-threatening fungi.世界卫生组织发布首份对健康构成威胁的真菌名单。
Saudi Med J. 2022 Nov;43(11):1284-1285.
6
Synthesis, Optimization, and Structure-Activity Relationships of Imidazo[1,2-]pyrimidines as Inhibitors of Group 2 Influenza A Viruses.咪唑并[1,2-]嘧啶类化合物的合成、优化及其作为 2 型流感病毒抑制剂的构效关系研究。
J Med Chem. 2022 Oct 27;65(20):14104-14120. doi: 10.1021/acs.jmedchem.2c01329. Epub 2022 Oct 19.
7
Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile.新型基于咪唑并嘧啶的分子诱导肿瘤丙酮酸激酶 M2 的四聚化,并表现出有效的抗增殖特性。
Eur J Pharm Sci. 2022 Mar 1;170:106112. doi: 10.1016/j.ejps.2021.106112. Epub 2021 Dec 28.
8
Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances.咪唑并吡啶,一种具有潜在药用应用和结构活性关系 (SAR) 的有前途的支架:最新进展。
J Biomol Struct Dyn. 2022;40(24):14279-14302. doi: 10.1080/07391102.2021.1997818. Epub 2021 Nov 15.
9
Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.咪唑并[1,2-b]哒嗪作为药物化学中的优势骨架:一篇广泛的综述。
Eur J Med Chem. 2021 Dec 15;226:113867. doi: 10.1016/j.ejmech.2021.113867. Epub 2021 Sep 23.
10
Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.吡咯烷在药物发现中的应用:一种新型生物活性化合物的多功能骨架。
Top Curr Chem (Cham). 2021 Aug 10;379(5):34. doi: 10.1007/s41061-021-00347-5.

咪唑并嘧啶:从相对奇特的骨架到药物研发中不断演变的结构基序。

Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery.

作者信息

Chowdhury Moumita Ghosh, Kalmegh Vaishnavi, Kapoor Saumya, Kamble Vaishnavi, Shard Amit

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Ahmedabad (NIPER-A) Opposite Airforce Station, Palaj Gandhinagar Gujarat-382355 India

出版信息

RSC Med Chem. 2024 Mar 13;15(5):1488-1507. doi: 10.1039/d3md00718a. eCollection 2024 May 22.

DOI:10.1039/d3md00718a
PMID:38784469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11110759/
Abstract

Nitrogen-fused heterocycles are of immense importance in modern drug discovery and development. Among them, imidazopyrimidine is a highly versatile scaffold with vast pharmacological utility. These compounds demonstrate a broad spectrum of pharmacological actions, including antiviral, antifungal, anti-inflammatory, and anticancer. Their adaptable structure allows for extensive structural modifications, which can be utilized for optimizing pharmacological effects structure-activity relationship (SAR) studies. Additionally, imidazopyrimidine derivatives are particularly noteworthy for their ability to target specific molecular entities, such as protein kinases, which are crucial components of various cellular signaling pathways associated with multiple diseases. Despite the evident importance of imidazopyrimidines in drug discovery, there is a notable lack of a comprehensive review that outlines their role in this field. This review highlights the ongoing interest and investment in exploring the therapeutic potential of imidazopyrimidine compounds, underscoring their pivotal role in shaping the future of drug discovery and clinical medicine.

摘要

氮杂环在现代药物研发中具有极其重要的意义。其中,咪唑并嘧啶是一种具有广泛药理用途的高度通用的骨架。这些化合物表现出广泛的药理作用,包括抗病毒、抗真菌、抗炎和抗癌。它们适应性强的结构允许进行广泛的结构修饰,可用于优化药理作用和构效关系(SAR)研究。此外,咪唑并嘧啶衍生物因其能够靶向特定分子实体(如蛋白激酶)而特别值得关注,蛋白激酶是与多种疾病相关的各种细胞信号通路的关键组成部分。尽管咪唑并嘧啶在药物研发中具有明显的重要性,但明显缺乏一篇全面概述其在该领域作用的综述。本综述强调了在探索咪唑并嘧啶化合物治疗潜力方面持续的兴趣和投入,突显了它们在塑造药物研发和临床医学未来方面的关键作用。